Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry

Launched by GLAXOSMITHKLINE · Aug 21, 2014

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Sufficient evidence to confirm that MENVEO exposure occurred within 28 days prior to conception or at any time during pregnancy
• • Sufficient information to determine whether the pregnancy is prospectively or retrospectively registered (ie, whether the outcome of pregnancy was known at the time of first contact with the registry)
• • Date the pregnancy exposure is registered
• • Full reporter (ie, HCP) contact information to allow for follow-up (name, address, etc.)
• Exclusion Criteria:

Trial Officials